Sarah Gheuens - Jul 1, 2025 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
Director
Signature
/s/ Jennifer Tousignant, Attorney-in-fact
Stock symbol
VRDN
Transactions as of
Jul 1, 2025
Transactions value $
$0
Form type
4
Date filed
7/2/2025, 04:43 PM
Previous filing
Jun 26, 2025
Next filing
Jul 11, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gheuens Sarah Director C/O VIRIDIAN THERAPEUTICS, INC., 221 CRESCENT STREET, SUITE 103A, WALTHAM /s/ Jennifer Tousignant, Attorney-in-fact 2025-07-02 0001881190

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRDN Stock Option (Right to Buy) Award $0 +21K $0.00 21K Jul 1, 2025 Common Stock 21K $14.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full upon the earlier to occur of (i) July 1, 2026 or (ii) the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service on the Board of Directors of the Issuer.